Literature DB >> 14708026

Peroxisome-proliferator-activated receptors and cancers: complex stories.

Liliane Michalik1, Béatrice Desvergne, Walter Wahli.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2004        PMID： 14708026     DOI： 10.1038/nrc1254

Source DB:  PubMed          Journal:  Nat Rev Cancer        ISSN： 1474-175X            Impact factor:   60.716


× No keyword cloud information.
  202 in total

Review 1.  Crosstalk of oncogenic and prostanoid signaling pathways.

Authors:  Rolf Müller
Journal:  J Cancer Res Clin Oncol       Date:  2004-06-15       Impact factor: 4.553

2.  Activation of PPARalpha Attenuates IFNgamma and IL-1beta-induced Cell Proliferation in Astrocytes: Involvement of IL-6 Independent Pathway.

Authors:  Jin-Koo Lee; Eun-Min Seo; Sang-Soo Lee; Soo-Hyun Park; Yun-Beom Sim; Jun-Sub Jung; Seon-Mi Kim; Hong-Won Suh
Journal:  Korean J Physiol Pharmacol       Date:  2010-06-30       Impact factor: 2.016

3.  Proteome-wide dysregulation by PRA1 depletion delineates a role of PRA1 in lipid transport and cell migration.

Authors:  Hao-Ping Liu; Chih-Ching Wu; Hung-Yi Kao; Yi-Chuan Huang; Ying Liang; Chia-Chun Chen; Jau-Song Yu; Yu-Sun Chang
Journal:  Mol Cell Proteomics       Date:  2010-06-30       Impact factor: 5.911

4.  Sprouty-4 inhibits transformed cell growth, migration and invasion, and epithelial-mesenchymal transition, and is regulated by Wnt7A through PPARgamma in non-small cell lung cancer.

Authors:  Meredith A Tennis; Michelle M Van Scoyk; Scott V Freeman; Katherine M Vandervest; Raphael A Nemenoff; Robert A Winn
Journal:  Mol Cancer Res       Date:  2010-05-25       Impact factor: 5.852

5.  Role of peroxisome proliferator-activated receptors alpha and gamma in gastric ulcer: An overview of experimental evidences.

Authors:  Lekha Saha
Journal:  World J Gastrointest Pharmacol Ther       Date:  2015-11-06

6.  Identification and Molecular Characterization of Peroxisome Proliferator-Activated Receptor δ as a Novel Target for Covalent Modification by 15-Deoxy-Δ12,14-prostaglandin J2.

Authors:  Aravind T Reddy; Sowmya P Lakshmi; Asoka Banno; Raju C Reddy
Journal:  ACS Chem Biol       Date:  2018-11-29       Impact factor: 5.100

7.  Potentiation of colon cancer susceptibility in mice by colonic epithelial PPAR-δ/β overexpression.

Authors:  Xiangsheng Zuo; Min Xu; Jiang Yu; Yuanqing Wu; Micheline J Moussalli; Ganiraju C Manyam; Sun Il Lee; Shoudan Liang; Mihai Gagea; Jeffrey S Morris; Russell R Broaddus; Imad Shureiqi
Journal:  J Natl Cancer Inst       Date:  2014-03-28       Impact factor: 13.506

8.  MicroRNA-130b promotes tumor development and is associated with poor prognosis in colorectal cancer.

Authors:  Tommaso Colangelo; Alessandra Fucci; Carolina Votino; Lina Sabatino; Massimo Pancione; Carmelo Laudanna; Monica Binaschi; Mario Bigioni; Carlo Alberto Maggi; Domenico Parente; Nicola Forte; Vittorio Colantuoni
Journal:  Neoplasia       Date:  2013-09       Impact factor: 5.715

9.  Protective effect of pioglitazone, a PPARγ agonist against acetaminophen-induced hepatotoxicity in rats.

Authors:  Gaurav Gupta; Gopala Krishna; Dinesh Kumar Chellappan; Kumar Shiva Gubbiyappa; Mayuren Candasamy; Kamal Dua
Journal:  Mol Cell Biochem       Date:  2014-04-27       Impact factor: 3.396

10.  Peroxisome proliferator-activated receptor beta/delta expression and activation in lung cancer.

Authors:  Tetyana V Pedchenko; Adriana L Gonzalez; DingZhi Wang; Raymond N DuBois; Pierre P Massion
Journal:  Am J Respir Cell Mol Biol       Date:  2008-06-19       Impact factor: 6.914
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.